HPV and TCT cannot usually detect endometrial cancer in its early stages, but TCT may detect endometrial cancer when the cancerous tissue is shed to the cervix or when the endometrial cancer further invades the cervix. HPV, or human papillomavirus, is a screening test for HPV infection; TCT, or cervical exfoliative cytology, is a screening test for cervical cell lesions and their condition; most endometrial cancers are slow-growing, and in early stages, the lesions are confined to the endometrium or inside the uterine cavity, and the cervix is usually free of any special changes, therefore, endometrial cancer cannot normally be detected by HPV and TCT tests. Endometrial cancer may be detected by TCT if the cancerous lesions are shedding and the cancerous tissue sometimes sheds to the cervix or even detaches from the cervical opening, or if the endometrial cancer develops further and invades the cervix, when these situations occur, endometrial cancer may be detected by HPV and TCT. Usually, HPV and TCT are combined to screen cervical cancer, and endometrial cancer is diagnosed by histological examination after segmental scraping; it is recommended to go to the hospital and have a reasonable examination under the guidance of the doctor to avoid delaying the condition.